PM
IMDX
Penbrook Management’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-207,675
| Closed | -$73.6K | – | 100 |
|
|
2023
Q1 | $73.6K | Hold |
207,675
| – | – | 0.06% | 94 |
|
|
2022
Q4 | $66.6K | Sell |
207,675
-355,675
| -63% | -$114K | 0.06% | 94 |
|
|
2022
Q3 | $411K | Sell |
563,350
-12,400
| -2% | -$9.05K | 0.35% | 70 |
|
|
2022
Q2 | $518K | Sell |
575,750
-2,400
| -0.4% | -$2.16K | 0.41% | 65 |
|
|
2022
Q1 | $861K | Hold |
578,150
| – | – | 0.56% | 55 |
|
|
2021
Q4 | $1.26M | Buy |
578,150
+950
| +0.2% | +$2.06K | 0.76% | 41 |
|
|
2021
Q3 | $2.06M | Buy |
577,200
+155,425
| +37% | +$553K | 1.28% | 20 |
|
|
2021
Q2 | $2.42M | Sell |
421,775
-2,000
| -0.5% | -$11.5K | 1.45% | 15 |
|
|
2021
Q1 | $2.2M | Hold |
423,775
| – | – | 1.58% | 14 |
|
|
2020
Q4 | $1.01M | Buy |
423,775
+194,350
| +85% | +$465K | 0.78% | 45 |
|
|
2020
Q3 | $319K | Buy |
229,425
+13,800
| +6% | +$19.2K | 0.28% | 80 |
|
|
2020
Q2 | $412K | Hold |
215,625
| – | – | 0.41% | 70 |
|
|
2020
Q1 | $529K | Buy |
215,625
+38,747
| +22% | +$95.1K | 0.68% | 43 |
|
|
2019
Q4 | $398K | Buy |
+176,878
| New | +$398K | 0.39% | 75 |
|